Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 50, 2020 - Issue 4
200
Views
5
CrossRef citations to date
0
Altmetric
General Xenobiochemistry

Bergamottin can be used to assess CYP3A-mediated intestinal first-pass metabolism without affecting P-glycoprotein-mediated efflux in rats

, , &
Pages 401-407 | Received 26 Mar 2019, Accepted 12 Jul 2019, Published online: 01 Aug 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Xinjuan Zhang, Jinyao Guo, Jin Li, Chen Chen & Guijun Su. (2022) Pharmacokinetics and pharmacodynamic interaction of bergamottin with atorvastatin in rats. Xenobiotica 52:5, pages 463-467.
Read now
Junmei Chen, Jinman Liu, Yueyue Huang, Ruoyu Li, Cuiru Ma, Beiping Zhang, Fanchang Wu, Wenqian Yu, Xue Zuo, Yong Liang & Qi Wang. (2021) Insights into oral bioavailability enhancement of therapeutic herbal constituents by cytochrome P450 3A inhibition. Drug Metabolism Reviews 53:4, pages 491-507.
Read now

Articles from other publishers (3)

Yusuke Tanaka, Kazuhiro Ito, Takanori Kurakazu & Satoshi Kasaoka. (2023) Separate Evaluation of Fraction Absorbed and Intestinal Availability after Oral Administration of Drugs Based on the Measurement of Portal and Systemic Plasma Concentrations and Luminal Concentration. Molecular Pharmaceutics 20:4, pages 1933-1941.
Crossref
Ebru Yazıcı, Elif Şahin, Elif Alvuroğlu, Esin Yuluğ & Ahmet Menteşe. (2023) Bergamottin reduces liver damage by suppressing inflammation, endoplasmic reticulum and oxidative stress in cafeteria diet-fed mice. Food Bioscience 52, pages 102371.
Crossref
Camila Juliana Domínguez, Guillermo Nicolás Tocchetti, Juan Pablo Rigalli & Aldo Domingo Mottino. (2021) Acute regulation of apical ABC transporters in the gut. Potential influence on drug bioavailability. Pharmacological Research 163, pages 105251.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.